# Trial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric Cancer

> **NCT01716546** · PHASE1,PHASE2 · TERMINATED · sponsor: **Hellenic Oncology Research Group** · enrollment: 51 (actual)

## Conditions studied

- Gastric Cancer

## Interventions

- **DRUG:** Pazopanib

## Key facts

- **NCT ID:** NCT01716546
- **Lead sponsor:** Hellenic Oncology Research Group
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-07
- **Primary completion:** 2015-01
- **Final completion:** 2015-01
- **Target enrollment:** 51 (ACTUAL)
- **Why stopped:** Not reached the primary endpoint target according to the statistical design
- **Last updated:** 2015-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01716546

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01716546, "Trial of Panitumumab Cisplatin, Fluourouracil and Docetaxel in Locally Advanced or Metastatic Gastric Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01716546. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*